Cargando…

Stereotactic Radiotherapy for Brain Metastases: Imaging Tools and Dosimetric Predictive Factors for Radionecrosis

Radionecrosis (RN) is the most important side effect after stereotactic radiotherapy (SRT) for brain metastases, with a reported incidence ranging from 3% to 24%. To date, there are no unanimously accepted criteria for iconographic diagnosis of RN, as well as no definitive dose-constraints correlate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lupattelli, Marco, Alì, Emanuele, Ingrosso, Gianluca, Saldi, Simonetta, Fulcheri, Christian, Borghesi, Simona, Tarducci, Roberto, Aristei, Cynthia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565332/ https://www.ncbi.nlm.nih.gov/pubmed/32635476 http://dx.doi.org/10.3390/jpm10030059

Ejemplares similares

Stereotactic radiotherapy for brain oligometastases
por: Lupattelli, Marco, et al.
Publicado: (2022)

Stereotactic radiotherapy for oligometastases in the lymph nodes
por: Pasqualetti, Francesco, et al.
Publicado: (2022)

Stereotactic radiotherapy for brain metastases: predictive factors of radionecrosis
por: Calderon, Benoît, et al.
Publicado: (2023)

Stereotactic radiotherapy for liver oligometastases
por: Menichelli, Claudia, et al.
Publicado: (2022)

Physician And Patient Barriers To Radiotherapy Service Access: Treatment Referral Implications
por: Chierchini, Sara, et al.
Publicado: (2019)

Radiobiology of stereotactic radiotherapy
por: Mangoni, Monica, et al.
Publicado: (2022)

Doses, fractionations, constraints for stereotactic radiotherapy
por: Borghesi, Simona, et al.
Publicado: (2022)

Stereotactic radiotherapy for lung oligometastases
por: Falcinelli, Lorenzo, et al.
Publicado: (2022)

Prognostic Genomic Tissue-Based Biomarkers in the Treatment of Localized Prostate Cancer
por: Ingrosso, Gianluca, et al.
Publicado: (2022)

Stereotactic radiotherapy for bone oligometastases
por: Colosimo, Caterina, et al.
Publicado: (2022)

Stereotactic radiotherapy for adrenal oligometastases
por: Borghesi, Simona, et al.
Publicado: (2022)

Effect of internal port on dose distribution in post-mastectomy radiotherapy for breast cancer patients after expander breast reconstruction
por: Perrucci, Elisabetta, et al.
Publicado: (2023)

Stereotactic radiotherapy of oligometastatic disease: a new paradigm for a curative approach
por: Krengli, Marco, et al.
Publicado: (2022)

Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis
por: Minniti, Giuseppe, et al.
Publicado: (2011)

Personalization in Modern Radiation Oncology: Methods, Results and Pitfalls. Personalized Interventions and Breast Cancer
por: Aristei, Cynthia, et al.
Publicado: (2021)

Integrating stereotactic radiotherapy and systemic therapies
por: Palumbo, Isabella, et al.
Publicado: (2022)

Breakdown of Symbiosis in Radiation-Induced Oral Mucositis
por: Ingrosso, Gianluca, et al.
Publicado: (2021)

Special stereotactic radiotherapy techniques: procedures and equipment for treatment simulation and dose delivery
por: Paoletti, Lisa, et al.
Publicado: (2022)

RADI-32. INTRACRANIAL CONTROL AND RADIONECROSIS IN MELANOMA PATIENTS WITH BRAIN METASTASES TREATED WITH STEREOTACTIC RADIOSURGERY
por: Tjong, Michael, et al.
Publicado: (2019)

Tomotherapy-based moderate hypofractionation for localized prostate cancer: a mono-institutional analysis
por: Tenti, Maria Valentina, et al.
Publicado: (2022)

Palliative short-course radiotherapy (RAPASH study) in patients with rectal cancer
por: Lupattelli, Marco, et al.
Publicado: (2023)

Updated risk models demonstrate low risk of symptomatic radionecrosis following stereotactic radiosurgery for brain metastases
por: Peng, Luke, et al.
Publicado: (2019)

Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failure
por: Leu, Justin, et al.
Publicado: (2023)

Cone-beam computed tomography in hypofractionated stereotactic radiotherapy for brain metastases
por: Ingrosso, Gianluca, et al.
Publicado: (2012)

Local control and radionecrosis of brain metastases from non-small-cell lung cancer treated by hypofractionated stereotactic radiotherapy: Evaluation of predictive factors
por: Leyrat, Brice, et al.
Publicado: (2022)

Feasibility of a Novel Sparse Orthogonal Collimator–Based Preclinical Total Marrow Irradiation for Enhanced Dosimetric Conformality
por: Abdelhamid, Amr M. H., et al.
Publicado: (2022)

Corrigendum: Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failure
por: Leu, Justin, et al.
Publicado: (2023)

Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Metastases
por: Weykamp, Fabian, et al.
Publicado: (2022)

Rodent Model of Brain Radionecrosis Using Clinical LINAC-Based Stereotactic Radiosurgery
por: Devan, Sean P., et al.
Publicado: (2022)

Current emerging MRI tools for radionecrosis and pseudoprogression diagnosis
por: Nichelli, Lucia, et al.
Publicado: (2021)

Radionecrosis and cellular changes in small volume stereotactic brain radiosurgery in a porcine model
por: Zaer, Hamed, et al.
Publicado: (2020)

Dosimetric comparison of different treatment modalities for stereotactic radiotherapy
por: Hsu, Shih-Ming, et al.
Publicado: (2017)

Impact of total marrow/lymphoid irradiation dose to the intestine on graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for hematologic malignancies
por: Saldi, Simonetta, et al.
Publicado: (2022)

Symptomatic radionecrosis after postoperative but not preoperative stereotactic radiosurgery in a single patient: illustrative case
por: Laurin, Bryce J, et al.
Publicado: (2023)

Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases
por: Halasz, Lia M., et al.
Publicado: (2013)

Omission of adjuvant radiotherapy for older adults with early-stage breast cancer particularly in the COVID era: A literature review (on the behalf of Italian Association of Radiotherapy and Clinical Oncology)
por: Palumbo, Isabella, et al.
Publicado: (2021)

The impact of emphysema on dosimetric parameters for stereotactic body radiotherapy of the lung
por: Ochiai, Satoru, et al.
Publicado: (2016)

Cognitive and neuropsychiatric impairment in cerebral radionecrosis patients after radiotherapy of nasopharyngeal carcinoma
por: Wu, Xiaohong, et al.
Publicado: (2014)

A Multi-Disciplinary Approach to Diagnosis and Treatment of Radionecrosis in Malignant Gliomas and Cerebral Metastases
por: Mangesius, Julian, et al.
Publicado: (2022)

The Incidence and Its Associated Factors Relevant to Brain Radionecrosis That Requires Intervention Following Single or Fractionated Stereotactic Radiosurgery Using Vero4DRT for Brain Metastases
por: Yamada, Takehiro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jkjsnl99i0rjj5f2rosa4u2hj4